EPHA2 and gastric cancer: Silencing of C1GALT1 decreased tyrosine phosphorylation of EPHA2, inhibited binding of Ephrin A1 to cell surfaces, and suppressed soluble Ephrin A1-induced migration in gastric cancer cells.